FDA Inspection 1257098 — Sanjit S. Jolly
The FDA completed an inspection of Sanjit S. Jolly on Dec 5, 2024 in Hamilton. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 5, 2024
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Hamilton (Canada)
Additional Details
Clinical Investigator (CI)